Literature DB >> 7201125

Cerebral blindness in association with cis-platinum chemotherapy for advanced carcinoma of the fallopian tube.

S B Diamond, S H Rudolph, S S Lubicz, G Deppe, C J Cohen.   

Abstract

A 62-year-old woman with a diagnosis of metastatic fallopian tube carcinoma was treated with cis-platinum and doxorubicin (Adriamycin) at a dosage of 50 mg/m2 intravenously every 3 weeks. After the 10th course of cis-platinum and doxorubicin, she complained of headache and inability to see. Physical examination was compatible with cortical blindness. The brain scan and computed tomographic scan were normal. Visual evoked potentials showed a delay in latency. Visual acuity completely returned over the next months, but right homonymous hemianopia persists. The temporal relationship between the findings and the treatment with platinum implicates this drug as the possible causative agent in the cortical blindness.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201125

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Transient blindness and seizure associated with cisplatin therapy.

Authors:  M T Cattaneo; V Filipazzi; E Piazza; E Damiani; G Mancarella
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

2.  Chemotherapy of eyelid and peritorbital tumors.

Authors:  M N Luxenberg; T H Guthrie
Journal:  Trans Am Ophthalmol Soc       Date:  1985

Review 3.  Interferon-related cortical blindness.

Authors:  O Merimsky; P Nisipeanu; A Loewenstein; I Reider-Groswasser; S Chaitchik
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.